Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lomitapide

EU orphan designation number: EU/3/10/823   
Active ingredient: Lomitapide
Indication: Treatment of familial chylomicronaemia
Sponsor: Aegerion Pharmaceuticals
37/39 avenue Ledru Rollin, F-75012 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2010 Centralised Orphan - Designation EMA/OD/089/10 (2010)9536 of 17/12/2010
21/02/2012 Centralised Orphan - Transfer of orphan designation EMA/OD/089/10/T/01 (2012)1108 of 15/02/2012
08/03/2013 Other procedure